Joseph C. Beyer

1.7k total citations
29 papers, 947 citations indexed

About

Joseph C. Beyer is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Joseph C. Beyer has authored 29 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 8 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Molecular Biology. Recurrent topics in Joseph C. Beyer's work include Immunotoxicology and immune responses (4 papers), HIV Research and Treatment (4 papers) and Retinal Diseases and Treatments (4 papers). Joseph C. Beyer is often cited by papers focused on Immunotoxicology and immune responses (4 papers), HIV Research and Treatment (4 papers) and Retinal Diseases and Treatments (4 papers). Joseph C. Beyer collaborates with scholars based in United States, Switzerland and France. Joseph C. Beyer's co-authors include William P. Cheevers, Anne Ryan, Lisa A. Damico, Jacques Gaudreault, David Fei, Linda Rangell, Noël Dybdal, Kirsten Achilles Poon, Surinder Kaur and Ola M. Saad and has published in prestigious journals such as Journal of Virology, Clinical Cancer Research and Annals of the Rheumatic Diseases.

In The Last Decade

Joseph C. Beyer

28 papers receiving 893 citations

Peers

Joseph C. Beyer
Hajir Dadgostar United States
M E Dorf United States
Asim V. Farooq United States
Nagaraj Kerur United States
E I Walter United States
Aaron R. Ellison United States
Hajir Dadgostar United States
Joseph C. Beyer
Citations per year, relative to Joseph C. Beyer Joseph C. Beyer (= 1×) peers Hajir Dadgostar

Countries citing papers authored by Joseph C. Beyer

Since Specialization
Citations

This map shows the geographic impact of Joseph C. Beyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph C. Beyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph C. Beyer more than expected).

Fields of papers citing papers by Joseph C. Beyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph C. Beyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph C. Beyer. The network helps show where Joseph C. Beyer may publish in the future.

Co-authorship network of co-authors of Joseph C. Beyer

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph C. Beyer. A scholar is included among the top collaborators of Joseph C. Beyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph C. Beyer. Joseph C. Beyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Couch, Jessica A., Gu Zhang, Joseph C. Beyer, et al.. (2015). Balancing Efficacy and Safety of an Anti-DLL4 Antibody through Pharmacokinetic Modulation. Clinical Cancer Research. 22(6). 1469–1479. 20 indexed citations
3.
Patnaik, Amita, Patricia LoRusso, Wells A. Messersmith, et al.. (2014). A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 73(5). 951–960. 61 indexed citations
4.
Zabka, Tanja S., Jatinder Singh, Preeti Dhawan, et al.. (2014). Retinal Toxicity, in vivo and in vitro, Associated with Inhibition of Nicotinamide Phosphoribosyltransferase. Toxicological Sciences. 144(1). 163–172. 58 indexed citations
5.
Poon, Kirsten Achilles, Kelly M. Flagella, Joseph C. Beyer, et al.. (2013). Preclinical safety profile of trastuzumab emtansine (T-DM1): Mechanism of action of its cytotoxic component retained with improved tolerability. Toxicology and Applied Pharmacology. 273(2). 298–313. 140 indexed citations
6.
McKeever, Kathleen, et al.. (2010). Developmental Immunotoxicology Assessment of Rituximab in Cynomolgus Monkeys. Toxicological Sciences. 119(1). 116–125. 42 indexed citations
7.
Gaudreault, Jacques, David Fei, Joseph C. Beyer, et al.. (2007). PHARMACOKINETICS AND RETINAL DISTRIBUTION OF RANIBIZUMAB, A HUMANIZED ANTIBODY FRAGMENT DIRECTED AGAINST VEGF-A, FOLLOWING INTRAVITREAL ADMINISTRATION IN RABBITS. Retina. 27(9). 1260–1266. 148 indexed citations
8.
Vugmeyster, Yulia, Joseph C. Beyer, Kathy Howell, et al.. (2005). Depletion of B Cells by a Humanized Anti-CD20 Antibody PRO70769 in Macaca Fascicularis. Journal of Immunotherapy. 28(3). 212–219. 60 indexed citations
9.
Kim, Ivana K., Deeba Husain, Norman Michaud, et al.. (2005). Effect of Intravitreal Injection of Ranibizumab in Combination with Verteporfin PDT on Normal Primate Retina and Choroid. Investigative Ophthalmology & Visual Science. 47(1). 357–357. 44 indexed citations
10.
Clarke, Janet, Susanne Pippig, Amita Joshi, et al.. (2004). Evaluation of a surrogate antibody for preclinical safety testing of an anti-CD11a monoclonal antibody. Regulatory Toxicology and Pharmacology. 40(3). 219–226. 47 indexed citations
11.
Miller, Paul E., Christian Bueger, Joseph C. Beyer, et al.. (2003). 26-Week Intravitreal Injection Toxicity Study with rhuFab Vegf in Cynomolgus Monkeys with an 8-Week Recovery. Investigative Ophthalmology & Visual Science. 44(13). 3929–3929. 3 indexed citations
12.
Beyer, Joseph C., et al.. (2003). An embryo-fetal development study in cynomolgus monkeys with rituximab, an anti-CD20 antibody. Toxicological Sciences. 72. 172. 1 indexed citations
13.
Snekvik, Kevin, Joseph C. Beyer, Giuseppe Bertoni, et al.. (2001). Characterization of caprine interleukin-4. Veterinary Immunology and Immunopathology. 78(3-4). 219–229. 6 indexed citations
15.
Bueger, Christian, P. Elliott Miller, Robert A. Leedle, et al.. (2000). Safety evaluation of intravitreal administration of rhuFab VEGF in cynomolgus monkeys for 3 months. 41(4). 14215. 1 indexed citations
17.
Balasuriya, Udeni B. R., James F. Evermann, Jodi F. Hedges, et al.. (1998). Serologic and molecular characterization of an abortigenic strain of equine arteritis virus isolated from infective frozen semen and an aborted equine fetus. Journal of the American Veterinary Medical Association. 213(11). 1586–1589. 44 indexed citations
18.
Henry, Carolyn J., et al.. (1996). Acute lymphoblastic leukemia, hypercalcemia, and pseudohyperkalemia in a dog. Journal of the American Veterinary Medical Association. 208(2). 237–239. 10 indexed citations
19.
Tyler, Jeff W., et al.. (1996). Clostridial Myonecrosis, Hepatitis, and Nephritis in a Llama With Vegetative Endocarditis. Journal of Veterinary Internal Medicine. 10(2). 94–96. 2 indexed citations
20.
Foreyt, William J., Stewart C. Schell, & Joseph C. Beyer. (1996). PROUTERINA WESCOTTI N. GEN., N. SP. (TREMATODA: PROUTERINIDAE N. FAM.) FROM THE BRAIN, LUNGS, AND NASAL SINUSES OF A BLACK BEAR (URSUS AMERICANUS) FROM IDAHO. Journal of Wildlife Diseases. 32(2). 225–233. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026